A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs
- 13 July 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (91) , 91ra63
- https://doi.org/10.1126/scitranslmed.3002304
Abstract
Disruption of the cooperative action of multiple copies of a drug target explains the high antiviral activity of the most active HIV drugs.Keywords
This publication has 31 references indexed in Scilit:
- Retroviral intasome assembly and inhibition of DNA strand transferNature, 2010
- HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 InfectivityJournal of Biological Chemistry, 2009
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugsNature Medicine, 2008
- Inhibition of Human Immunodeficiency Virus Type 1 Concerted Integration by Strand Transfer Inhibitors Which Recognize a Transient Structural IntermediateJournal of Virology, 2007
- Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1Journal of Virology, 2005
- A Novel Parameter to Estimate the Minimum Number of Bound Ligands Needed to Activate an Ion ChannelJournal of Theoretical Biology, 1999
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981